Tiffany Vora: Longevity & the Future Is 150 the Next 80 | EDGE 2026
3m 27s
In this forward-looking session at EDGE 2026 in Sydney, Tiffany Vora challenges leaders to rethink aging, healthspan, and lifespan through the lens of biotechnology and exponential technologies.
Drawing on advances in gene editing, immunotherapy, AI-enabled health monitoring, and the emerging science of the biological hallmarks of aging, Vora explores the possibility that aging may be modifiable rather than inevitable. The session reframes longevity not as living forever, but as delaying age-related disease and extending healthy, productive decades.
Beyond biology, the talk examines the leadership, workforce, generational, and societal implications of radically longer lives, asking what it means for careers, succession planning, retirement, and intergenerational responsibility.
Key Takeaways:
• Aging may be biologically modifiable through emerging biotech interventions.
• Extending healthspan, not just lifespan, reshapes leadership and workforce models.
• Radical longevity forces new ethical, societal, and generational accountability questions.